Beetroot juice ingestion does not improve neuromuscular performance and match‑play demands in elite female hockey players: a randomized, double‑blind, placebo‑controlled study
Abstract
. Purpose Beetroot juice is a dietary supplement that contains high levels of inorganic nitrate (NO3-) and that its intake has
proven efective at increasing blood nitric oxide (NO) concentrations improving endurance performance. However, the efect
of this supplement in team sport performance, especially in female athletes, has been barely studied. This study aimed to
compare the acute efects of beetroot juice supplementation on neuromuscular performance and match-play demands in
elite female feld hockey players.
Methods Eleven elite female hockey players (22.8±5.1 years) belonging to a bronze team medal in Eurohockey Club
Champions Cup participated in this study. Participants were randomly divided into two groups undergoing a test battery
with beetroot juice (70 mL, 6.4 mmol NO3
−) or placebo (70 mL, 0.04 mmol NO3
−) in two diferent days with one week
between protocols. The neuromuscular test battery consisted of a countermovement jump, isometric handgrip strength (i.e.,
dominant hand), 20 m-sprint and repeated sprint ability test (RSA). Afterward, a simulated hockey match play (2×12.5 min)
was performed and recorded by Global Positioning System (GPS).
Results No statistically signifcant improvements were observed in any physical parameters analysed comparing beetroot
juice compared to placebo ingestion, countermovement jump (p=0.776, ES=0.16), isometric handgrip strength (p=0.829;
ES=– 0.08), 20 m sprint test (p=0.227; ES=– 0.23), mean repeated sprint ability (p=0.955, ES=0.03) and in any physical
match demands measured by GPS (p=0.243–1.000; ES=0.02–0.47).
Conclusion Acute beetroot juice supplementation did not produce any statistically signifcant improvement in neuromuscular
performance or match-play demands in elite female feld hockey players.
Trial registration The study was registered in ClinicalTrials.gov with the following ID: NCT05209139. The study was retrospectively registered by 26 January 2022.